Novel homo-and hemizygous mutations in EZH2 in myeloid malignancies
H Makishima, AM Jankowska, RV Tiu, H Szpurka… - Leukemia, 2010 - nature.com
Leukemia, 2010•nature.com
3 Horton JK, Prasad R, Hou E, Wilson SH. Protection against methylation-induced
cytotoxicity by DNA polymerase b-dependent long patch base excision repair. J Biol Chem
2000; 275: 2211–2218. 4 Liuzzi M, Talpaert-Borle M. A new approach to study of the base
excision repair pathway using methoxyamine. J Biol Chem 1985; 260: 5252–5258. 5 Liu L,
Taverna P, Whitacre CM, Chatterjee S, Gerson SL. Pharmacological disruption of base
excision repair sensitizes mismatch repair deficient and proficient colon cancer cells to …
cytotoxicity by DNA polymerase b-dependent long patch base excision repair. J Biol Chem
2000; 275: 2211–2218. 4 Liuzzi M, Talpaert-Borle M. A new approach to study of the base
excision repair pathway using methoxyamine. J Biol Chem 1985; 260: 5252–5258. 5 Liu L,
Taverna P, Whitacre CM, Chatterjee S, Gerson SL. Pharmacological disruption of base
excision repair sensitizes mismatch repair deficient and proficient colon cancer cells to …
3 Horton JK, Prasad R, Hou E, Wilson SH. Protection against methylation-induced cytotoxicity by DNA polymerase b-dependent long patch base excision repair. J Biol Chem 2000; 275: 2211–2218. 4 Liuzzi M, Talpaert-Borle M. A new approach to study of the base excision repair pathway using methoxyamine. J Biol Chem 1985; 260: 5252–5258.
5 Liu L, Taverna P, Whitacre CM, Chatterjee S, Gerson SL. Pharmacological disruption of base excision repair sensitizes mismatch repair deficient and proficient colon cancer cells to methylating agents. Clin Cancer Res 1999; 5: 2908–2917. 6 Yan L, Bulgar A, Miao YL, Mahajan V, Donze JR, Gerson SL, Liu L. Combined treatment with temozolomide and methoxyamine: blocking apurinic/pyrimidinic site repair coupled with targeting topoisomerase IIa. Clin Cancer Res 2007; 13: 1532–1539.
nature.com